They found that CD73 overexpression was correlated with poor prognosis in cancers including bladder, brain, invasive lobular breast, esophageal, gastric, pancreatic, rectal mucinous, renal cell, lung large cell, oral squamous cell carcinoma, melanoma, and lung adenocarcinoma. This evidence concerns the gene NT5E and melanoma.